Statins and peripheral neuropathy: causation or coincidence?

British National Formulary, www.bnf.org.uk . London: BMJ Group, 2010 (accessed 20 October 2010).

Jacobs MB HMG-CoA reductase inhibitor therapy and peripheral neuropathy. Ann Intern Med 1994;120:11.

Jeppesen U. , Gaist D. , Smith T. , Sindrup SH Statins and peripheral neuropathy. Eur J Clin Pharmacol 1999;54:835-8.

Gaist D. , Jeppesen U. , Andersen M. et al. Statins and risk of polyneuropathy: a case-control study. Neurology 2002;58:1333-7.

Otruba P. , Kanovsky P. , Hlustik P. Treatment with statins and involvement of the peripheral nervous system: results of a prospective clinical and neurophysiological follow-up. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:307-10.

Daglioglu E. , Berker M. , Demirci M. et al. Microscopic and electrophysiological changes on regenerating sciatic nerves of rats treated with simvastatin. Folia Neuropath 2010;48:49-56.

Sirvent P. , Mercier J. , Lacampagne A. New insights into mechanisms of statin-associated myotoxicity. Curr Opin Pharmacol 2008;8:333-8.

Golomb BA , Evans MA Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs 2008;8:373-418.

Davis TME , Yeap BB , Davis WA , Bruce DG Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2008;51:562-6.

Beghi E. , Monticelli ML Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation of risk factors for polyneuropathy in two Italian communities. Italian General Practitioner Study Group (IGPST). J Clin Epidemiol 1998;51:697-702.